z-logo
open-access-imgOpen Access
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Author(s) -
E.E. Tolley,
S.Z. Zangeneh,
G. Chau,
JJ Eron,
B. Grinsztejn,
H. Humphries,
A. Liu,
M. Siegel,
M. Bertha,
R. Panchia,
S. Li,
L. Cottle,
A. Rinehart,
D. Margolis,
A. Jennings,
M. McCauley,
R.J. Landovitz
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/nwrk-cv03
Subject(s) - human immunodeficiency virus (hiv) , virology , medicine , pharmacology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom